Life Sciences & Healthcare
In a dynamic environment where changing regulatory requirements, long product cycles, complex intellectual property rights and cost pressure on healthcare pose constant challenges for our clients, we offer you access to our extensive team of savvy experts. Not only are they legally qualified; they also have a deep understanding of the relevant technical and business-related issues in the life sciences and healthcare sectors.
Life Sciences is a key consulting area for our firm, where we have special expertise and proven track record, providing you with comprehensive support with pharmaceuticals, biotech, healthcare, medtech and digital health.
Areas of Expertise
Our specialists can advise you in the following areas in particular:
- Developing intellectual property strategies, patent management and exploitation of intellectual property rights, supplementary protection certificates and extensions of paediatric rights; freedom-to-operate investigations;
- National and cross-border M&A and private equity transactions and financing for pharmaceutical, biotech, healthcare and medtech companies as well as structuring and implementing joint ventures and other cooperation agreements;
- Hospital financing and cooperations;
- Distribution and supply agreements, cooperation agreements, license agreements, manufacturing agreements, research and development agreements, employee invention agreements;
- Patent litigation (infringement proceedings, invalidity proceedings, assignment and ownership disputes, licensing disputes);
- Other commercial arbitration and litigation in the field of life sciences and health care;
- Regulatory advice and compliance regarding the Therapeutic Products Act (regulatory data protection, advice on pharmaceutical products, cooperations with HCPs and HCOs etc.);
- Advertising law regarding therapeutic products, trademark law and other labelling issues regarding pharmaceuticals, biotech and medtech;
- Pricing of therapeutic products and representation before the Federal Office of Public Health
- Competition law advice (price differentiation, distribution channel planning etc.);
- E-health, data management, data protection strategies, advice in connection with digital business ideas and online platforms;
- Outsourcing projects;
- Product recall procedures
Team
- Renato Bucher
- Lukas Bühlmann
- Ulrike Ciesla
- Frédéric Cottier
- Kevin M. Hubacher
- Markus Frank Huber
- L. Mattias Johnson
- Mark Montanari
- Michael Reinle
- Michael Ritscher
- Marc A. Schamaun
- Daniel Schoch
- Peter Schramm
- Kilian Schärli
- Andrea Sieber
- Mona Stephenson
- Julie Wynne
- Nadine von Büren-Maier
- Daniel Donauer
- Louisa Galbraith
- Noemi Bünter
- Ada Sofie Altobelli
- Andrea Heiniger
- Cédric Saladin
- Franziska Schweizer
“MLL Legal has outstanding expertise in Swiss regulatory law and, in my view, is the go-to-firm whenever you have a question in this field. You will receive a well-founded opinion/recommendation on specific questions/for a certain case within a very short time that is supported by case law and related publications and that provides a valuable basis for decisions your client has to made”
Publications
The Healtcare Law Review: Switzerland
7th Edition, 2023, Editor Ulrich Grau, Chapter 13, p. 139 - 152- EN
Arzneimittelrechtliche Werberegulierung
MLL Legal (Hrsg.), Praxishandbuch Produktregulierung, Bern 2023, S. 563 ff.- DE
Schweizerische Chemikalienregulierung
MLL Legal (Hrsg.), Praxishandbuch Produktregulierung, Bern 2023, S. 377 ff.- DE
Schweizerische Cannabisregulierung
MLL Legal (Hrsg.), Praxishandbuch Produktregulierung, Bern 2023, S. 313 ff.- DE